211 related articles for article (PubMed ID: 7537098)
1. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
[TBL] [Abstract][Full Text] [Related]
2. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
[TBL] [Abstract][Full Text] [Related]
3. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
Arai S; Teramoto S; Senoo Y
J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
[TBL] [Abstract][Full Text] [Related]
4. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
6. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
Harrison PC; Mainolfi E; Madwed JB
J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
[TBL] [Abstract][Full Text] [Related]
8. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
Aharoni R; Yussim A; Sela M; Arnon R
Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
13. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine.
Herskowitz A; Tamura F; Ueda K; Neumann DA; Slepian M; Rose NR; Beschorner WE; Baumgartner WA; Reitz BR; Sell KW
J Heart Transplant; 1989; 8(1):11-9. PubMed ID: 2647926
[TBL] [Abstract][Full Text] [Related]
14. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
Koskinen PK; Lemström KB; Häyry PJ
Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of graft coronary arteriosclerosis after heart transplantation.
Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
[TBL] [Abstract][Full Text] [Related]
16. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Bouchard D; Despatis MA; Buluran J; Cartier R
Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
[TBL] [Abstract][Full Text] [Related]
19. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
[No Abstract] [Full Text] [Related]
20. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]